Manufacturing Line Lonza Provides Biotherapeutics Manufacturing Capacity for Alexion

Editor: Dominik Stephan

Under a new agreement, Lonza will provide additional manufacturing capcity for Alexion at its site site in Portsmouth, New Hampshire.

Related Companies

(Picture: Ernhofer/PROCESS)

Basel/Switzerland; Portsmouth, New Hampshire/USA – Lonza announced the signing of a new long-term product supply agreement with Alexion. Under the agreement Lonza will construct and launch a new suite dedicated to Alexion manufacturing. Lonza will own and operate the suite as part of its Portsmouth, New Hampshire (USA) site. This contract is an expansion of an existing manufacturing agreement.

The expansion of the existing site in Portsmouth, near Boston, MA (USA), will provide valued customers increased access to Lonza’s proven biological manufacturing and regulatory expertise, experienced global workforce and high level of focused customer service. Lonza has more than two decades of worldwide manufacturing experience with mammalian biotherapeutics.